Wu; Songliang

Patent Applications and Registrations

Patent applications and USPTO patent grants for Wu; Songliang.The latest application filed is for "bicyclic compound as a caspase inhibitor".

Company Profile

10.8.8

Wu; Songliang - Nanjing CN
Wu; Songliang - Shanghai CN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Bicyclic compound as a caspase inhibitor Grant 11,434,212 - Mou , et al. September 6, 2	2022-09-06
Bicyclic Compound as a Caspase Inhibitor App 20210332019 - MOU; Jianfeng ; et al.	2021-10-28
Crystal of a caspase inhibitor Grant 11,091,450 - Wu , et al. August 17, 2	2021-08-17
Caspase inhibitor and pharmaceutical composition, use and therapeutic method thereof Grant 10,981,860 - He , et al. April 20, 2	2021-04-20
Crystal form of orexin receptor antagonist compound, and preparation method and application thereof Grant 10,912,775 - Wu , et al. February 9, 2	2021-02-09
Crystal form of orexin receptor antagonist compound, and preparation method and application thereof Grant 10,898,486 - Wu , et al. January 26, 2	2021-01-26
A Crystal Of A Caspase Inhibitor App 20210002235 - Wu; Songliang ; et al.	2021-01-07
Crystal form of orexin receptor antagonist compound, and preparation method and application thereof Grant 10,874,674 - Wu , et al. December 29, 2	2020-12-29
Crystal Form Of Orexin Receptor Antagonist Compound, And Preparation Method And Application Thereof App 20200261453 - WU; Songliang ; et al.	2020-08-20
Crystal Form Of Orexin Receptor Antagonist Compound, And Preparation Method And Application Thereof App 20200261452 - WU; Songliang ; et al.	2020-08-20
Crystal Form Of Orexin Receptor Antagonist Compound, And Preparation Method And Application Thereof App 20200253972 - Kind Code	2020-08-13
Crystal form of orexin receptor antagonist compound, and preparation method and application thereof Grant 10,668,066 - Wu , et al.	2020-06-02
Caspase Inhibitor And Pharmaceutical Composition, Use And Therapeutic Method Thereof App 20190135733 - He; Haiying ; et al.	2019-05-09
Piperidine derivatives as orexin receptor antagonist Grant 10,100,047 - He , et al. October 16, 2	2018-10-16
Crystal Form Of Orexin Receptor Antagonist Compound, And Preparation Method And Application Thereof App 20180235965 - WU; Songliang ; et al.	2018-08-23
Piperidine Derivatives As Orexin Receptor Antagonist App 20170233385 - HE; Haiying ; et al.	2017-08-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.